Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int Urogynecol J. 2016 Mar 4. [Epub ahead of print]

Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats.

Author information

  • 1Department of Health Sciences, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, University of Leicester, PO Box 65, Leicester, LE2 7LX, UK. evibakali@me.com.
  • 2School of Life Sciences, University of Nottingham, Nottingham, UK.
  • 3Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
  • 4Department of Health Sciences, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, University of Leicester, PO Box 65, Leicester, LE2 7LX, UK.

Abstract

INTRODUCTION AND HYPOTHESIS:

This study was designed to evaluate the effects of CP55,940 on normal bladder function in vivo and examine whether it suppresses urinary frequency induced by nociceptive stimuli in the bladder. Cannabinoid receptor (CBR) activity may be involved in the regulation of bladder function. However, the role of CBR subtypes in micturition has yet to be established. CP55,940 is a synthetic analogue of tetrahydrocannabidiol, which is a psychoactive ingredient of the Cannabis plant.

METHODS:

Cystometry under urethane anaesthesia was performed to evaluate the effect of intravesical delivery of CP55,940 with or without administration of CB1 antagonist AM251 or CB2 antagonist AM630 on bladder function in female rats. The effects of CP55,940 were also examined in rats with urinary irritation induced by intravesical infusion of acetic acid.

RESULTS:

Infusion of CP55,940 significantly (p < 0.05) increased micturition interval (MI) and bladder capacity (BC) by 52 % and decreased maximal voiding pressure (MP) by 25 %. Pretreatment with AM251 or AM630 before CP55,940 administration prevented CP55,940-induced increases in MI, BC and reduced MP. Acetic acid induced urinary frequency as evidenced by a reduction in MI and was suppressed by CP55,940.

CONCLUSIONS:

CP55,940 decreases bladder activity and urinary frequency induced by nociceptive stimuli, probably by suppression of bladder afferent activity. Effects of CP55,940 were abolished by both CBR antagonists. This data implicates a role for the endocannabinoid system in bladder mechanoafferent function in rats. In addition, our results show that CP55,940 reverses urinary frequency exemplified in an overactive bladder model, suggesting it could be an effective treatment for patients with lower urinary tract symptoms.

KEYWORDS:

Cannabinoid receptors; Cystometry; Overactive bladder; Urinary bladder

PMID:
26942594
[PubMed - as supplied by publisher]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk